A Randomized Double-Blind Study to Compare the Effect of RO4402257 Monotherapy and Methotrexate Monotherapy on Disease Response in Patients With Active Rheumatoid Arthritis.
Phase of Trial: Phase II
Latest Information Update: 02 May 2016
At a glance
- Drugs Pamapimod (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 01 Feb 2009 Primary endpoint results published in Arthritis and Rheumatism 60: 335-344, No. 2, Feb 2009
- 01 Feb 2009 Primary endpoint 'American College of Rheumatology 20% response criteria' has not been met.
- 19 Mar 2008 Status changed from in progress to completed based on information from ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History